drugset / Trial / NCT05806346

Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery

NCT05806346 ↗

RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

The present study is a multi-center randomized prospective placebo-controlled non-inferiority trial. The study's primary objective is to compare the amounts of postoperative bleeding using two different TXA administration strategies: empirical TXA administration vs. viscoelastic test-based goal-directed TXA administration in cardiovascular surgery. The secondary objectives include comparing the incidents of hyper-fibrinolysis, thromboembolic complications, and postoperative seizures. Researchers assumed that goal-directed tranexamic acid (TXA) administration using viscoelastic field tests would not be inferior to the empirical TXA administration strategy in reducing postoperative bleeding and hyper-fibrinolysis. It also would be beneficial in lowering TXA-induced thromboembolic complications and seizures.

Timeline

Start
2023-08-01
Primary completion
2025-04-30
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 2 mg/kg Intravenous
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous
Subject Tranexamic Acid Small molecule 20 mg/kg Intravenous